ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The House of Representatives Energy & Commerce Committee has endorsed legislation that would reauthorize and fine-tune a 2006 law aimed at making sure the federal government is prepared to respond to a biological, chemical, radioactive, or nuclear terrorist attack. Specifically, H.R. 2405 is intended to renew the Biomedical Advanced Research & Development Authority and Project BioShield. The programs, overseen by the Health & Human Services Department, provide funding to promote development and stockpiling of vaccines and other medical countermeasures for anthrax, smallpox, and other threats. Rep. Mike J. Rogers (R-Mich.), the bill’s sponsor, says the legislation is particularly important as the 10th anniversary of the Sept. 11, 2001, terrorist attacks approaches. “Bioterrorism still represents a real threat to this country,” Rogers noted at a committee hearing last month. “Simply put, we must always be prepared.” The bill now heads to the House floor. Meanwhile, the Senate Health, Education, Labor & Pensions Committee is drafting similar legislation.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X